{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T22:31:37Z","timestamp":1783031497114,"version":"3.54.6"},"reference-count":46,"publisher":"Elsevier BV","issue":"21","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.vaccine.2007.03.006","type":"journal-article","created":{"date-parts":[[2007,3,20]],"date-time":"2007-03-20T10:51:22Z","timestamp":1174387882000},"page":"4159-4169","source":"Crossref","is-referenced-by-count":44,"title":["Leishmania major heat shock protein 70 (HSP70) is not protective in murine models of cutaneous leishmaniasis and stimulates strong humoral responses in cutaneous and visceral leishmaniasis patients"],"prefix":"10.1016","volume":"25","author":[{"given":"Sima","family":"Rafati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Gholami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nafiseh","family":"Hassani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Ghaemimanesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasaman","family":"Taslimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahereh","family":"Taheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Soong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9115","key":"10.1016\/j.vaccine.2007.03.006_bib2","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/S0140-6736(98)09552-X","article-title":"Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran","volume":"351","author":"Sharifi","year":"1998","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.vaccine.2007.03.006_bib3","doi-asserted-by":"crossref","first-page":"6372","DOI":"10.1128\/IAI.73.10.6372-6382.2005","article-title":"Live nonpathogenic parasitic vector as a candidate vaccine against visceral leishmaniasis","volume":"73","author":"Breton","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.03.006_bib4","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1023\/A:1026047429604","article-title":"Present status of antileishmanial vaccines","volume":"253","author":"Ghosh","year":"2003","journal-title":"Mol Cell Biochem"},{"issue":"21\/5","key":"10.1016\/j.vaccine.2007.03.006_bib5","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.pt.2005.03.006","article-title":"Second-generation vaccines against leishmaniasis","author":"Coler","year":"2005","journal-title":"Trends Parasirol"},{"issue":"20","key":"10.1016\/j.vaccine.2007.03.006_bib6","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/S0264-410X(98)00075-9","article-title":"Vaccination with recombinant parasite surface antigen 2 from Leishmania major induces a Th1 type of immune response but does not protect against infection","volume":"16","author":"Sjolander","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.03.006_bib7","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1016\/j.vaccine.2006.01.030","article-title":"Comparison of potential protection induced by three vaccination strategies (DNA\/DNA, protein\/protein and DNA\/protein) against Leishmania major infection using signal peptidase type I in BALB\/c mice","volume":"24","author":"Rafati","year":"2006","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2007.03.006_bib8","doi-asserted-by":"crossref","first-page":"5842","DOI":"10.1128\/IAI.73.9.5842-5852.2005","article-title":"Vaccination with the Leishmania infantum acidic ribosomal P0 protein plus CpG oligodeoxynucleotides induces protection against cutaneous leishmaniasis in C57BL\/6 mice but does not prevent progressive disease in BALB\/c mice","volume":"73","author":"Iborra","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.03.006_bib9","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1128\/IAI.63.9.3559-3566.1995","article-title":"Leishmania pifanoi amastigote antigens protects mice against cutaneous leishmaniasis","volume":"63","author":"Soong","year":"1995","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.03.006_bib10","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1046\/j.1365-2249.2000.01160.x","article-title":"Vaccination of BALB\/c mice with Leishmania major amastigote-specific cysteine proteinase","volume":"120","author":"Rafati","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2007.03.006_bib11","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nri933","article-title":"The immunology of susceptible and resistance to Leishmania major in mice","volume":"2","author":"Sacks","year":"2002","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2007.03.006_bib12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.imlet.2005.01.009","article-title":"T helper (h)1\/Th2 and leishmania: paradox rather than paradigm","volume":"99","author":"Alexander","year":"2005","journal-title":"Immunol Lett"},{"key":"10.1016\/j.vaccine.2007.03.006_bib13","series-title":"Host-Derived Adjuvants. Novel Vaccination Strategies","author":"Hilf","year":"2004"},{"issue":"11","key":"10.1016\/j.vaccine.2007.03.006_bib14","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.drudis.2006.04.016","article-title":"Heat shock proteins as vaccine adjuvants in infections and cancer","volume":"11","author":"Segal","year":"2006","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.vaccine.2007.03.006_bib15","first-page":"279","article-title":"Heat shock proteins in immunity","volume":"172","author":"Multhoff","year":"2006","journal-title":"HEP"},{"key":"10.1016\/j.vaccine.2007.03.006_bib16","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1042\/BST0320629","article-title":"Functional domains of HSP70 stimulate generation of cytokines and chemokines, maturation of dendritic cells and adjuvanticity","volume":"32","author":"Lehner","year":"2004","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.vaccine.2007.03.006_bib17","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0301-472X(99)00104-6","article-title":"Heat shock protein 70 (Hsp70) stimulates proliferation and cytolytic activity of natural killer cells","volume":"27","author":"Multhoff","year":"1999","journal-title":"Exp Hematol"},{"key":"10.1016\/j.vaccine.2007.03.006_bib18","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/74697","article-title":"HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine","volume":"6","author":"Asea","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2007.03.006_bib19","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.immunol.20.100301.064801","article-title":"Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses","volume":"20","author":"Strivastava","year":"2002","journal-title":"Ann Rev Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2007.03.006_bib20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1128\/CMR.12.1.19","article-title":"Role of heat shock proteins in protection from and pathogenesis of infectious disease","volume":"12","author":"Z\u00fcgel","year":"1999","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"10.1016\/j.vaccine.2007.03.006_bib21","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/0014-5793(92)80309-5","article-title":"Imidazole-SDS-Zn reverse staining of proteins in gels containing or not SDS and microsequence of individual unmodified electroblotted proteins","volume":"296","author":"Oritz","year":"1992","journal-title":"FEBS"},{"key":"10.1016\/j.vaccine.2007.03.006_bib22","first-page":"4105","article-title":"Immune responses of leishmaniasis patients to heat shoch proteins of Leishmania species and human","volume":"63","author":"Skeiky","year":"1995","journal-title":"Infection"},{"key":"10.1016\/j.vaccine.2007.03.006_bib23","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1146\/annurev.iy.10.040192.002125","article-title":"Regulation of immunity to parasites by T cells and T cell-derived cytokines","volume":"10","author":"Sher","year":"1992","journal-title":"Ann Rev Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2007.03.006_bib24","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1379\/1466-1268(1996)001<0177:IOTCTR>2.3.CO;2","article-title":"Identification of the C-terminal region of 70kDa heat shock proteinfrom Leishmania (Viannia) braziliensis as a target for the human immune response","volume":"1","author":"Amorim","year":"1996","journal-title":"Cell Stress Chaperones"},{"key":"10.1016\/j.vaccine.2007.03.006_bib25","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1128\/IAI.60.7.2688-2693.1992","article-title":"Mapping of visceral leishmaniasis-specific Immunodominant B-cell Epitope of Leishmania donovani HSP70","volume":"60","author":"Wallace","year":"1992","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2007.03.006_bib26","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1590\/S0074-02761999000300015","article-title":"T cell response of asymptomatic Leishmania chagasi infected subjects to recombinant Leishmania antigens","volume":"94","author":"Costa","year":"1999","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.vaccine.2007.03.006_bib27","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1073\/pnas.92.14.6499","article-title":"The GroES homolog of Helicobacter pylori confers protective immunity against mucosal infection in mice","volume":"92","author":"Ferrero","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2007.03.006_bib28","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1128\/IAI.64.8.2955-2961.1996","article-title":"Immunity against Yersinia enterocolitica by vaccination with Yersinia hsp60 immunostimulating complexes or Yersinia hsp60 plus interleukin-12","volume":"64","author":"Noll","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.03.006_bib29","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1128\/IAI.63.7.2587-2595.1995","article-title":"Vaccination with recombinant heat shock protein 60 from Histoplasma capsulatum protects mice against pulmonary histoplasmosis","volume":"63","author":"Gomez","year":"1995","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.03.006_bib30","first-page":"244","article-title":"A single mycobacterial protein (hsp65) expressed by a transgenic antigen-presenting cell vaccinates mice against tuberculosis","volume":"82","author":"Silva","year":"1994","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2007.03.006_bib31","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1128\/IAI.66.1.169-175.1998","article-title":"Identification and characterization of protective T cells in hsp65 DNA-vaccinated and Mycobacterium tuberculosis-infected mice","volume":"66","author":"Bonato","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.03.006_bib32","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/0264-410X(94)90080-9","article-title":"Towards a DNA vaccine against tuberculosis","volume":"12","author":"Lowrie","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.03.006_bib33","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/nm0896-888","article-title":"Vaccination against tuberculosis by DNA injection","volume":"2","author":"Tascon","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2007.03.006_bib34","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S0264-410X(97)00073-X","article-title":"Protection against tuberculosis by a plasmid DNA vaccine","volume":"15","author":"Lowrie","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.03.006_bib35","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/22326","article-title":"Therapy of tuberculosis in mice by DNA vaccination","volume":"400","author":"Lowrie","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2007.03.006_bib36","doi-asserted-by":"crossref","first-page":"873","DOI":"10.4049\/jimmunol.156.2.873","article-title":"Adjuvant-free hsp70 fusion protein system elicits humoral and cellular immune responses to HIV-1 p24","volume":"156","author":"Suzue","year":"1996","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2007.03.006_bib37","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.vaccine.2004.08.033","article-title":"Enhancement of DNA vaccine potency by linkage a Plasmodium falciparum malaria antigen gene fused with a fragment of HSP70 gene","volume":"23","author":"Qazi","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.03.006_bib38","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0161-5890(99)00136-4","article-title":"Immunostimulatory properties of the Leishmania infantum heat shock proteins HSP70 and HSP83","volume":"36","author":"Rico","year":"1999","journal-title":"Mol Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2007.03.006_bib39","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1128\/IAI.66.1.347-352.1998","article-title":"Characterization of the immunostimulatory property of L. infantum HSP70 by fusion to the E. coli MBP in normal and nu\/nu BALB\/c mice","volume":"66","author":"Rico","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.03.006_bib40","doi-asserted-by":"crossref","first-page":"6270","DOI":"10.1128\/IAI.71.11.6270-6278.2003","article-title":"Immunization with the gene encoding a P4 nuclease of Leishmania amazonensis amastigotes protects mice against cutaneous leishmaniasis","volume":"71","author":"Campbell","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.03.006_bib41","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0165-2478(98)00071-6","article-title":"Analysis of the antigenic properties of the L. infantum HSP70: design of synthetic peptides for specific serodiagnosis of human leishmaniasis","volume":"63","author":"Quijada","year":"1998","journal-title":"Immunol Lett"},{"issue":"7","key":"10.1016\/j.vaccine.2007.03.006_bib42","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.vaccine.2005.12.050","article-title":"Novel vaccines for the treatment of chronic HBV infection based on mycobacterial heat shock protein 70","volume":"24","author":"Peng","year":"2006","journal-title":"Vaccine"},{"issue":"16","key":"10.1016\/j.vaccine.2007.03.006_bib43","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1016\/j.vaccine.2006.01.012","article-title":"A truncated C-terminal fragment of mycobacterium tuberculosis HSP70 gene enhanced potency of HBV DNA vaccine","volume":"24","author":"Li","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.03.006_bib44","doi-asserted-by":"crossref","first-page":"7046","DOI":"10.1016\/j.vaccine.2006.07.006","article-title":"The genetic immunization with paraflagellar rod protein-2 fused to the HSP70 confers protection against late Trypanosome cruzi infection","volume":"24","author":"Morell","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.03.006_bib45","doi-asserted-by":"crossref","first-page":"6558","DOI":"10.1128\/IAI.69.10.6558-6563.2001","article-title":"DNA immunization with Trypanosoma cruzi HSP70 fused to the KMP11 protein elicits a cytotoxic and humoral immune response against the antigen and leads to protection","volume":"69","author":"Planeller","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.03.006_bib46","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/j.vaccine.2003.11.014","article-title":"Immunization with the hybrid protein vaccine, consisting of Leishmania major cysteine proteases Type I (CPB) and Type II (CPA), partially protects against leishmaniasis","volume":"22","author":"Zadeh-Vakili","year":"2004","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2007.03.006_bib47","first-page":"21","article-title":"Identification of sero-specific epitope of recombinant heat shock protein (HSP70) of Leishmania donovani","volume":"24","author":"Arora","year":"2000","journal-title":"J Parasitic Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07003064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07003064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T03:30:30Z","timestamp":1683775830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07003064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":46,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S0264410X07003064"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.03.006","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}